Ontario’s FAST program aims to speed up access to breakthrough cancer drugs for patients by almost a full year sooner.[1] Itovebi offers a targeted treatment for advanced HR-positive, HER2-negative breast… Read More
Corcym, a global medical device company focused on advanced cardiac surgery solutions, announced that Health Canada has approved the Miami Instruments™ portfolio, a suite of minimally invasive surgical instruments designed… Read More
AISight® Dx will support fully digital workflows and AI-enabled insights across Labcorp’s network of anatomic pathology labs and hospital collaborations to improve efficiency, collaboration and patient care. BURLINGTON, N.C. –… Read More
Subcutaneous (SC) amivantamab reduces administration from hours to minutes, with efficacy and safety consistent with intravenous (IV) amivantamab1,2,3,4,5 SC amivantamab is now authorised across all previously approved IV indications, offering… Read More
Over half of respondents (55%) are unsure or do not know that their chronic health condition may increase their risk of developing shingles Majority (77%) fear disruption to daily life… Read More
